Vistagen Therapeutics (VTGN) Short term Debt (2011 - 2020)
Vistagen Therapeutics (VTGN) posted Short term Debt of $98400.0 for Q4 2020, down 72.09% sequentially from $352600.0 in Q3 2020, and up 39.57% YoY from $70500.0 in Q1 2020.
Vistagen Therapeutics (VTGN) Short term Debt (2011 - 2020) Analysis & Trends
Vistagen Therapeutics has reported Short term Debt for 9 years, with the latest figure at $98400.0 in Q4 2020.
- Quarterly Short term Debt rose 39.57% year-over-year to $98400.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $98400.0 (up 39.57% YoY) and the FY2020 annual result came in at $56500.0, down 1.4% from the prior year.
- Short term Debt eased to $98400.0 in Q4 2020 per VTGN's latest filing, from $352600.0 in the prior quarter.
- Over five years, Short term Debt peaked at $428900.0 in Q2 2020 and troughed at $35800.0 in Q4 2016.
- A 5-year average of $128788.9 and a median of $84450.0 in 2019 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2018 and 2020: Short term Debt decreased 1.64% in 2018, then soared 121.34% in 2020.
- Over 5 years, Short term Debt stood at $35800.0 in 2016, then grew by 22.07% to $43700.0 in 2017, then rose by 12.36% to $49100.0 in 2018, then surged by 43.58% to $70500.0 in 2019, then soared by 39.57% to $98400.0 in 2020.
- According to Business Quant data, Short term Debt over the past three periods registered $98400.0, $352600.0, and $428900.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Vistagen Therapeutics | 10.51 Mn | 10.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 98,400.00 |
| Sep 30, 2020 | 352,600.00 |
| Jun 30, 2020 | 428,900.00 |
| Mar 31, 2020 | 56,500.00 |
| Dec 31, 2019 | 70,500.00 |
| Sep 30, 2019 | 159,300.00 |
| Jun 30, 2019 | 246,400.00 |
| Mar 31, 2019 | 57,300.00 |
| Dec 31, 2018 | 49,100.00 |
| Sep 30, 2018 | 115,600.00 |
| Jun 30, 2018 | 181,100.00 |
| Mar 31, 2018 | 53,900.00 |
| Dec 31, 2017 | 43,700.00 |
| Sep 30, 2017 | 105,200.00 |
| Jun 30, 2017 | 165,500.00 |
| Mar 31, 2017 | 54,800.00 |
| Dec 31, 2016 | 35,800.00 |
| Mar 31, 2016 | 43,600.00 |
| Dec 31, 2014 | 4.30 Mn |
| Mar 31, 2014 | 3,600.00 |